메뉴 건너뛰기




Volumn 78, Issue 1, 1997, Pages 647-651

Analysis of factor VIII inhibitors using hybrid human/porcine factor VIII

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; EPITOPE; HYBRID PROTEIN;

EID: 0030858423     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657605     Document Type: Conference Paper
Times cited : (23)

References (39)
  • 1
    • 0027473752 scopus 로고
    • Previously untreated patient study group. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and the development of inhibitors
    • Lusher JM, Arkin S, Abildgaard CF, Schwartz RS, Kogenate. Previously untreated patient study group. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and the development of inhibitors. N Engl J Med 1993; 328:453-9.
    • (1993) N Engl J Med , vol.328 , pp. 453-459
    • Lusher, J.M.1    Arkin, S.2    Abildgaard, C.F.3    Schwartz, R.S.4    Kogenate5
  • 5
    • 0344776562 scopus 로고
    • Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli
    • Scandella D, Mahoney SD, Mattingly M, Roeder D, Timmons L, Fulcher CA. Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli. Proc. Natl. Acad. Sci. USA 1988; 85:6152-6
    • (1988) Proc. Natl. Acad. Sci. USA , vol.85 , pp. 6152-6156
    • Scandella, D.1    Mahoney, S.D.2    Mattingly, M.3    Roeder, D.4    Timmons, L.5    Fulcher, C.A.6
  • 6
    • 0024451521 scopus 로고
    • Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization
    • Scandella D, Mattingly M, de Graaf S, Fulcher CA. Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization. Blood 1989; 74:1618-26
    • (1989) Blood , vol.74 , pp. 1618-1626
    • Scandella, D.1    Mattingly, M.2    De Graaf, S.3    Fulcher, C.A.4
  • 7
    • 0027250069 scopus 로고
    • A recombinant factor VIII A2 domain polypeptide quantitatively neutralizes human inhibitor antibodies which bind to A2
    • Scandella D, Mattingly M Prescott R. A recombinant factor VIII A2 domain polypeptide quantitatively neutralizes human inhibitor antibodies which bind to A2. Blood 1993; 82:1767-75.
    • (1993) Blood , vol.82 , pp. 1767-1775
    • Scandella, D.1    Mattingly, M.2    Prescott, R.3
  • 8
    • 1842390308 scopus 로고
    • Properties of affinity purified anti-factor VIII antibodies from patients with factor VIII inhibitors
    • Nakai H, Lollar P, Healey JF, Scandella D. Properties of affinity purified anti-factor VIII antibodies from patients with factor VIII inhibitors. Blood 1994; 84:224a.
    • (1994) Blood , vol.84
    • Nakai, H.1    Lollar, P.2    Healey, J.F.3    Scandella, D.4
  • 9
    • 0344265156 scopus 로고    scopus 로고
    • Epitope of a hemophilia A inhibitor antibody overlaps the factor VIII binding site for factor IX
    • Abstr
    • Zhong D, Scandella D. Epitope of a hemophilia A inhibitor antibody overlaps the factor VIII binding site for factor IX. Blood 1996; 88:324a (Abstr.)
    • (1996) Blood , vol.88
    • Zhong, D.1    Scandella, D.2
  • 10
    • 0027488655 scopus 로고
    • Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction
    • Gilles JGG, Arnout J, Vermylen J, Saint-Remy J-MR. Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction. Blood 1993; 82:2452-61.
    • (1993) Blood , vol.82 , pp. 2452-2461
    • Gilles, J.G.G.1    Arnout, J.2    Vermylen, J.3    Saint-Remy, J.-M.R.4
  • 12
    • 0024328077 scopus 로고
    • Molecular basis of factor-VIII inhibition by human antibodies-antibodies that bind to the factor-VIII light chain prevent the interaction of factor-VIII with phosphotipid
    • Arai M, Scandella D, Hoyer LW. Molecular basis of factor-VIII inhibition by human antibodies-antibodies that bind to the factor-VIII light chain prevent the interaction of factor-VIII with phosphotipid. J Clin Invest 1989; 83:1978-84.
    • (1989) J Clin Invest , vol.83 , pp. 1978-1984
    • Arai, M.1    Scandella, D.2    Hoyer, L.W.3
  • 13
    • 0027457180 scopus 로고
    • A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit binding to von Willebrand factor and to phosphatidylserine
    • Shima M, Scandella D, Yoshioka A, Nakai H, Tanaka I, Kamisue S, Terada S, Fukui H. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit binding to von Willebrand factor and to phosphatidylserine. Thromb Haemostas 1993; 69:240-6.
    • (1993) Thromb Haemostas , vol.69 , pp. 240-246
    • Shima, M.1    Scandella, D.2    Yoshioka, A.3    Nakai, H.4    Tanaka, I.5    Kamisue, S.6    Terada, S.7    Fukui, H.8
  • 14
    • 0026720912 scopus 로고
    • A soluble recombinant factor VIII fragment containing the A2 domain binds to some human anti-factor VIII antibodies that are not detected by immunoblotting
    • Scandella D, Timmons L, Mattingly M, Trabold N, Hoyer LW. A soluble recombinant factor VIII fragment containing the A2 domain binds to some human anti-factor VIII antibodies that are not detected by immunoblotting. Thromb Haemostas 1992; 67: 665-71.
    • (1992) Thromb Haemostas , vol.67 , pp. 665-671
    • Scandella, D.1    Timmons, L.2    Mattingly, M.3    Trabold, N.4    Hoyer, L.W.5
  • 16
    • 0029030435 scopus 로고
    • Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII
    • Healey JF, Lubin IM, Nakai H, Saenko EL, Hoyer LW, Scandella D, Lollar P. Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII. J Biol Chem 1995; 270:14505-9.
    • (1995) J Biol Chem , vol.270 , pp. 14505-14509
    • Healey, J.F.1    Lubin, I.M.2    Nakai, H.3    Saenko, E.L.4    Hoyer, L.W.5    Scandella, D.6    Lollar, P.7
  • 17
    • 0029166916 scopus 로고
    • Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII
    • Koshihara K, Qian J, Lollar P, Hoyer LW. Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII. Blood 1995; 86:2183-90.
    • (1995) Blood , vol.86 , pp. 2183-2190
    • Koshihara, K.1    Qian, J.2    Lollar, P.3    Hoyer, L.W.4
  • 18
    • 0027050152 scopus 로고
    • Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide
    • Ware J, MacDonald MJ, Lo M, de Graaf S, Fulcher CA. Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide. Blood Coagul Fibrinolysis 1992; 3:703-16.
    • (1992) Blood Coagul Fibrinolysis , vol.3 , pp. 703-716
    • Ware, J.1    MacDonald, M.J.2    Lo, M.3    De Graaf, S.4    Fulcher, C.A.5
  • 19
    • 0029154988 scopus 로고
    • Some human inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248-2312 which overlap a phospholipid binding site
    • Scandella D, Gilbert GE, Shima M, Nakai H, Eagleson C, Felch M, Prescott R, Rajalakshmi KJ, Hoyer LW, Saenko E. Some human inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248-2312 which overlap a phospholipid binding site. Blood 1995; 86:1811-9.
    • (1995) Blood , vol.86 , pp. 1811-1819
    • Scandella, D.1    Gilbert, G.E.2    Shima, M.3    Nakai, H.4    Eagleson, C.5    Felch, M.6    Prescott, R.7    Rajalakshmi, K.J.8    Hoyer, L.W.9    Saenko, E.10
  • 20
    • 0027457180 scopus 로고
    • A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine
    • Shima M, Scandella D, Yoshioka A, Hanai H, Tanaka I, Kamisue S, Terada S, Fukui H. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine. Thromb Haemost 1993; 69: 240-6.
    • (1993) Thromb Haemost , vol.69 , pp. 240-246
    • Shima, M.1    Scandella, D.2    Yoshioka, A.3    Hanai, H.4    Tanaka, I.5    Kamisue, S.6    Terada, S.7    Fukui, H.8
  • 21
    • 0009499522 scopus 로고    scopus 로고
    • Expression of a recombinant hybrid human/porcine factor VIII molecule with reduced reactivity toward anti-C2 domain inhibitory antibodies
    • Healey J F, Scandella D, Lollar P. Expression of a recombinant hybrid human/porcine factor VIII molecule with reduced reactivity toward anti-C2 domain inhibitory antibodies. Blood 1996; 88: 658a.
    • (1996) Blood , vol.88
    • Healey, J.F.1    Scandella, D.2    Lollar, P.3
  • 23
    • 0024504877 scopus 로고
    • Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis
    • Cunningham BC, Jhurani P, Ng P, Wells JA. Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science 1989; 243:1330-6.
    • (1989) Science , vol.243 , pp. 1330-1336
    • Cunningham, B.C.1    Jhurani, P.2    Ng, P.3    Wells, J.A.4
  • 24
    • 0022760260 scopus 로고
    • A large region (approximately equal to 95 kDa) of human factor VIII is dispensible for in vitro procoagulant activity
    • Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ. A large region (approximately equal to 95 kDa) of human factor VIII is dispensible for in vitro procoagulant activity. Proc Natl Acad Sci USA 1986; 83:5939-42.
    • (1986) Proc Natl Acad Sci USA , vol.83 , pp. 5939-5942
    • Toole, J.J.1    Pittman, D.D.2    Orr, E.C.3    Murtha, P.4    Wasley, L.C.5    Kaufman, R.J.6
  • 25
    • 0029909770 scopus 로고    scopus 로고
    • The cDNA and derived amino acid sequence of porcine factor VIII
    • Healey JF, Lubin IM, Lollar P. The cDNA and derived amino acid sequence of porcine factor VIII. Blood 1996; 88:4209-14.
    • (1996) Blood , vol.88 , pp. 4209-4214
    • Healey, J.F.1    Lubin, I.M.2    Lollar, P.3
  • 26
    • 0027196024 scopus 로고
    • Sequence of the murine factor VIII cDNA
    • Elder B, Lakich D, Gitschier J. Sequence of the murine factor VIII cDNA. Genomics 1993; 16:374-9.
    • (1993) Genomics , vol.16 , pp. 374-379
    • Elder, B.1    Lakich, D.2    Gitschier, J.3
  • 28
    • 0025351555 scopus 로고
    • Epitopes on protein antigens: Misconceptions and realities
    • Laver WG, Air GM, Webster RG, Smith-Gill SJ. Epitopes on protein antigens: misconceptions and realities. Cell 1990; 61: 553-6.
    • (1990) Cell , vol.61 , pp. 553-556
    • Laver, W.G.1    Air, G.M.2    Webster, R.G.3    Smith-Gill, S.J.4
  • 29
    • 0026675750 scopus 로고
    • High resolution functional analysis of antibody-antigen interactions
    • Jin L, Fendly BM, Wells JA. High resolution functional analysis of antibody-antigen interactions. J Mol Biol 1992; 226:851-65.
    • (1992) J Mol Biol , vol.226 , pp. 851-865
    • Jin, L.1    Fendly, B.M.2    Wells, J.A.3
  • 30
    • 3042958993 scopus 로고    scopus 로고
    • The X-ray structure of human serum ceruloplasmin at 3.1 Angstroms: Nature of the copper centres
    • Ziatseva I, Zaitsev V, Card G, Moshkov K, Bax B, Ralph A, Lindley P. The X-ray structure of human serum ceruloplasmin at 3.1 Angstroms: nature of the copper centres. JBIC 1996; 1:15-23.
    • (1996) JBIC , vol.1 , pp. 15-23
    • Ziatseva, I.1    Zaitsev, V.2    Card, G.3    Moshkov, K.4    Bax, B.5    Ralph, A.6    Lindley, P.7
  • 31
    • 85088329815 scopus 로고    scopus 로고
    • A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human caeruloplasmin
    • in press
    • Pemberton S, Lindley P, Zaitsev V, Card G, Tuddenham EGD, Kemball-Cook G. A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human caeruloplasmin. Blood, in press.
    • Blood
    • Pemberton, S.1    Lindley, P.2    Zaitsev, V.3    Card, G.4    Tuddenham, E.G.D.5    Kemball-Cook, G.6
  • 32
    • 0029931340 scopus 로고    scopus 로고
    • Inhibitors in congenital haemophilia
    • Brettler DM. Inhibitors in congenital haemophilia. Bailliere's Clin Haematol 1996; 9:319-29.
    • (1996) Bailliere's Clin Haematol , vol.9 , pp. 319-329
    • Brettler, D.M.1
  • 33
    • 1842359422 scopus 로고
    • Drug utilization and economics of patient care in acquired hemophilia
    • Kessler CM (ed.), Princeton: Excerpta Medica
    • Kessler CM. Drug utilization and economics of patient care in acquired hemophilia. In Kessler CM (ed.), Acquired Hemophilia. Princeton: Excerpta Medica, 1995; 131-47.
    • (1995) Acquired Hemophilia , pp. 131-147
    • Kessler, C.M.1
  • 34
    • 0027522777 scopus 로고
    • Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders
    • Hedner U, Glazer S, Falch J. Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders. Transfusion Med Rev 1993; 7:78-83.
    • (1993) Transfusion Med Rev , vol.7 , pp. 78-83
    • Hedner, U.1    Glazer, S.2    Falch, J.3
  • 35
    • 0029550057 scopus 로고
    • Porcine factor VIII therapy in patients with factor VIII inhibitors
    • Aledort LM, Hoyer LW, Lusher JM, Reisner HM, White GC II (eds.), New York: Plenum Press
    • Hay C, Lozier JN. Porcine factor VIII therapy in patients with factor VIII inhibitors. In Aledort LM, Hoyer LW, Lusher JM, Reisner HM, White GC II (eds.), Inhibitors to Coagulation Factors. New York: Plenum Press, 1995; 143-51.
    • (1995) Inhibitors to Coagulation Factors , pp. 143-151
    • Hay, C.1    Lozier, J.N.2
  • 36
    • 0021293334 scopus 로고
    • Porcine factor VIII: Preparation and use in treatment of inhibitor patients
    • Hoyer LW (ed), New York: Alan R. Liss
    • Kernoff PBA. Porcine factor VIII: preparation and use in treatment of inhibitor patients. In Hoyer LW (ed), Factor VIII Inhibitors. New York: Alan R. Liss, 1984; 207-24.
    • (1984) Factor VIII Inhibitors , pp. 207-224
    • Kernoff, P.B.A.1
  • 38
    • 0027389602 scopus 로고
    • The development of homologous (canine/anti-canine) antibodies in dogs with hemophilia A (factor VIII) deficiency: A ten-year longitudinal study
    • Tinlin S, Webster S, Giles AR. The development of homologous (canine/anti-canine) antibodies in dogs with hemophilia A (factor VIII) deficiency: a ten-year longitudinal study. Thromb Haemost 1993; 69:21-4.
    • (1993) Thromb Haemost , vol.69 , pp. 21-24
    • Tinlin, S.1    Webster, S.2    Giles, A.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.